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IMPLICATIONS ANDPurpose: To estimate the point prevalence of self-medication among adolescents aged 18 years
and to evaluate the type of drugs used (either over-the-counter or prescription drugs) and
socioeconomic, health-related, and behavioral correlates of self-medication.
Methods: This cross-sectional study useddata from the 1993 Pelotas (Brazil) Birth Cohort Study. Data
were obtained through the administration of a questionnaire to adolescents aged 18 years. The
outcomevariableswerepointprevalenceofmedicineuseandself-medicationcollectedbyself-report.
The independent variables studied were gender, continuous medicine use, socioeconomic status,
schooling, self-rated health, body mass index, and physical activity levels. Medicines were classiﬁed
into therapeutic groups according to the Anatomical Therapeutic Chemical classiﬁcation system.
Results: A total of 4,106 adolescents were interviewed. The point prevalence of medicine use was
41.1% (95% conﬁdence interval [CI] 39.6e42.6), and the proportion of self-medication among
medicine users was 65.1% (95% CI 62.8e67.4). The point prevalence of self-medication was 26.7%
(95% CI 25.4e28.1), and it was higher among female adolescents, those more educated, and those
who rated their health as poor. Out of the drugs used for self-medication (58% of all drugs used),
1,003 (78.7%) were nonprescription drugs and 271 (21.3%) were prescription drugs. The most
frequently used drugs for self-medication were analgesics (56.1%), systemic antihistamines (7.4%),
and anti-inﬂammatory and antirheumatic products (7.1%).
Conclusions: A high point prevalence of self-medication was found among adolescents, which is
particularly concerning due to high use of prescription drugs for self-medication. Interventions are
needed to promote rational use of medicines in this population.
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The proportion of self-
medication among medi-
cine users was high
(65.1%), and for continuous
medication, self-medication
reached 18.7%. Strategies to
promote rational drug use
are needed addressing is-
sues related to drug use,
from elementary and high
school, as they can poten-
tially lead to behavior
changes toward the rational
use of medicines.Self-medication is a widespread practice regarded by the
World Health Organization (WHO) as being part of self-care. Self-
medication is deﬁned as the selection and use of medicines by
individuals to treat self-recognized or self-diagnosed conditions
or symptoms. WHO recognizes this practice as responsible when
the individual uses products that are approved and available
without the need of medical prescription [1]. It is important totp://creativecommons.org/licenses/by-
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larly among those individuals who are becoming more inde-
pendent and encouraged to bemore independent about self-care.
In Brazil, as in most countries, the age of 18 years is a legal
milestone into adulthood when adolescents can enjoy adult
privileges. Yet, the road to adulthood involves exploring various
levels of independence and responsibilities under adult su-
pervision. This transition from adolescence into young adult-
hood is often characterized by going off to college, joining the
military, marrying and becoming a parent [2]. This transition
period can affect one’s health andmedicine use due to increases
in the prevalence of sexually transmitted diseases, obesity,
smoking and alcohol use, as well as decreases in physical ac-
tivity practice [3].
Appropriate and responsible self-medication has been asso-
ciated with several beneﬁts including increased access to medi-
cines, active patient role, and promotion of self-care and
optimization of the use of public resources for the treatment of
mild or minor health conditions [4]. However, self-medication is
not always safe, as it may be related to incorrect self-diagnosis,
delays in seeking medical advice when needed, infrequent but
severe adverse reactions, dangerous drug interactions, incorrect
manner of administration, incorrect dosage, incorrect choice of
therapy, masking of a severe disease, and risk of dependence and
abuse [4e7].
Only nonprescription, over-the-counter (OTC) drugs should
be used through self-medication. According to WHO guidelines,
OTCs must be safe, reliable, effective, easy to use, and convenient
[1]. In Brazil, however, many pharmacies do not comply with the
mandatory requirement of presenting a medical prescription for
the purchase of prescription drugs, which facilitates its use
through self-medication. The implications of this harmful prac-
tice and its potential damaging health effects are of great
concern.
The prevalence of self-medication in Brazil and worldwide
has been estimated between 10.3% and 87.0% varying according
to the population studied and methods used [4,8e19]. The drugs
most frequently used through self-medication are analgesics and
antipyretics, nonsteroidal anti-inﬂammatory drugs, and antimi-
crobials [8,9,12,15,18,20]. Studies about self-medication in ado-
lescents are rare. In three previous studies, the prevalence of
self-medication ranged from 26.7% to 56.6% [14,17,18].
Previous studies have shown that medicine use is strongly
associated with gender [13,17,21], socioeconomics position,
schooling [15,16], and self-rated health [14,22]. We are interested
in investigating whether these variables also inﬂuence self-
medication in this age group. Body mass index (BMI) has
proved directly associated with medicine use in adults [23,24]. In
addition, physical activity was shown to be inversely associated
with medicine use [25]. The effect of these two variables on
medicine use and self-medication in adolescents was seldom
explored. There is also a literature gap on the use of medicines
that require medical prescription through self-medication, a fact
that indicates lack of control in medicine dispensing. This would
be of particular concern in a country like Brazil, where such
medicines should be only used with medical prescription. The
same concern was raised in Europe, Asia, and Latin American
concerning the use of antibiotics [8,26e28].
This study aimed to assess the point prevalence of self-
medication among adolescents aged 18 years, the type of drugs
used (either OTC or prescription drugs), and socioeconomic,
health-related, and behavioral correlates of self-medication.Methods
Pelotas is a southern Brazilian city with around 330,000 in-
habitants in 2010. All live births in city hospitals in the calendar
year of 1993, of mothers living in the urban area of the city of
Pelotas, Brazil, were included in the 1993 Pelotas (Brazil) Birth
Cohort Study. Of the 5,265 eligible mothers of children born that
year, 5,249 agreed to participate. Subsamples of these children
were followed up at ages 1, 3, and 6 months and 1, 3, 6, and
9 years. The ﬁrst follow-up visit to all cohort members took place
when participants were aged 11 years. Follow-ups of the entire
cohort were also carried out at the ages of 15 and 18 years.
The 18 years follow-up visit took place between September
2011 and March 2012. Adolescents were invited to attend the
Postgraduate Program in Epidemiology outpatient clinic, where
they underwent medical examinations and ﬁlled out question-
naires. Further details on the methods used in previous cohort
visits can be found elsewhere [29,30]. Data onmedicine usewere
collected during the follow-up at the age of 18 years through self-
report.
We assessed two outcomes at the individual level: point
prevalence of medicine use and point prevalence of self-
medication. We deﬁned medicine use as the use of at least one
medicine in the 15 days preceding the interview, independent if
it was an eventual use or an ongoing use (i.e., continuous use),
and we deﬁned self-medication as the use of at least one medi-
cine without a current medical prescription in the 15 days prior
to the interview. Information on advice for medicine use was
collected and categorized as current medical prescription,
noncurrent medical prescription, or nonmedical advice (by a
family member, friend, nonmedical health professional, and
others).
The independent variables studied were gender; continuous
medicine use (daily or almost daily use with no end date); so-
cioeconomic position (an index was constructed based on a score
of household assets; the sum of items was entered in a principal
component analysis and the ﬁrst factor was extracted; we then
divided this factor into quintiles to represent ﬁfths of socioeco-
nomic position; the assets originally included in the question-
naire were those collected in standardized socioeconomic
position classiﬁcation systems in Brazil [31]); schooling (up to
8 years; 9e11 years), self-rated health (excellent, good, regular,
fair, poor); BMI (low, normal, overweight, obese according to the
WHO criteria for 18-year-old adolescents) [32]; and physical
activity (a cutoff of 300 minutes or more per week of commuting
or leisure-time physical activity was used to classify participants
as active) [33].
We also conducted analyses using the total number of drugs
used as the denominator. The reported drugs were divided into
groups following the Anatomical Therapeutic Chemical (ATC)
classiﬁcation system [34], level 1 classiﬁed drugs by main
anatomical group and level 2 according to pharmacological/
therapeutic subgroups. Medicines were also categorized as
nonprescription (OTC) or prescription drugs according to the
current Brazilian regulations [35].
The analyses were performed using Stata 11.2 (StataCorp,
College Station, TX). First, we conducted a description of the in-
dependent variables and then calculated the point prevalence of
medicine use and overall self-medication stratiﬁed by gender
and continuous medicine use. We used the chi-square test for
heterogeneity at a 5% level of signiﬁcance and calculated 95%
conﬁdence intervals (CIs) of the main estimates.
Table 1
Distribution and point prevalence of self-medication among adolescents aged 18 years from the 1993 Pelotas Birth Cohort according to the socioeconomic, health-
related, and behavioral variables
Total Sample Medicine use Self-medication
Males Females Total % Males Females Total %
N % Overall
usea %
Continuous
useb %
Overall
use %
Continuous
use %
Overall
use %
Continuous
use %
Overall
use %
Continuous
use %
4,106 100 32.1 5.3 49.8 19.0 41.1 23.1 8.1 30.2 26.4 26.7
Quintiles of
socioeconomic
position
p ¼ .250 p ¼ .244 p < .001 p < .001 p < .001 p ¼ .689 p ¼ .150 p ¼ .100 p ¼ .798 p ¼ .368
1st (poorest) 837 20.4 32.4 7.3 42.9 16.1 38.8 22.6 8.1 27.7 27.7 25.7
2nd 803 19.6 27.8 3.5 44.8 14.3 36.2 21.1 2.4 28.0 25.0 24.5
3rd 821 20.0 33.5 5.3 46.8 16.2 40.3 25.5 8.8 29.2 22.8 27.4
4th 822 20.0 31.6 5.2 56.0 23.2 42.8 23.0 12.8 35.1 29.3 28.6
5th (wealthiest) 820 20.0 34.9 5.5 61.4 26.8 47.2 23.2 7.8 32.3 26.8 27.4
Schooling (years) p ¼ .035 p ¼ .490 p < .001 p < .001 p < .001 p ¼ .738 p ¼ .502 p ¼ .019 p ¼ .768 p ¼ .007
Up to 8 1,859 45.3 30.0 4.9 42.7 13.5 35.4 22.9 7.4 27.2 25.7 24.7
9 to 11 2,245 54.7 54.1 5.6 54.1 22.3 45.8 23.5 9.1 32.1 26.8 28.5
Self-rated health p < .001 p ¼ .008 p ¼ .175 p ¼ .103 p < .001 p ¼ .002 p ¼ .671 p ¼ .002 p ¼ .567 p < .001
Poor/very poor 158 3.9 47.8 11.9 55.0 26.4 51.9 32.8 13.6 31.9 27.6 32.3
Fair 698 17.0 41.3 7.6 53.3 20.6 48.6 30.1 9.6 36.5 30.5 34.0
Good 2,433 59.3 30.8 4.9 49.2 18.7 40.2 22.6 7.9 29.7 25.3 26.2
Excellent 816 19.9 27.5 3.7 46.2 15.8 35.1 19.3 6.4 23.7 23.1 21.1
BMI p ¼ .027 p ¼ .099 p ¼ .914 p ¼ .248 p ¼ .152 p ¼ .152 p ¼ .781 p ¼ .739 p ¼ .111 p ¼ .598
Low 299 7.5 24.0 4.0 50.0 8.3 36.7 20.0 .0 37.5 .0 28.6
Normal 2,573 64.8 30.5 4.4 49.8 18.6 40.1 22.5 8.1 30.8 25.7 26.6
Overweight 739 18.6 32.9 6.0 51.6 19.1 42.9 23.0 10.5 32.5 26.9 28.0
Obese 363 9.1 40.8 8.4 48.9 22.9 45.2 29.8 7.0 29.2 35.4 29.5
Physically activec p ¼ .389 p ¼ .325 p ¼ .196 p ¼ .258 p ¼ .007 p ¼ .253 p ¼ .784 p ¼ .367 p ¼ .288 p ¼.172
Yes 2,497 61.5 31.5 4.9 51.3 20.0 39.5 22.6 8.0 31.2 28.3 26.1
No 1,563 38.5 33.5 6.0 48.5 18.0 43.7 25.1 8.8 29.4 24.6 28.0
p < .001: medicine use and self-medication among males and females.
BMI ¼ body mass index.
a Overall use: use of at least one medicine in the 15 days preceding the interview for acute or continuous use.
b Continuous use: use of at least one medicine in the 15 days preceding the interview, only for continuous use.
c Physically active ¼ 300 min/week or more of commuting or leisure-time physical activity.
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overall and stratiﬁed byOTC or prescription drugs.We conducted
further analyses to characterize drugs used for self-medication:
most frequently used drugs; major therapeutic classes; and
OTC or prescription drug categorization.
This research project followed the principles of the Declara-
tion of Helsinki and was approved by the Research Ethics Com-
mittee of the School of Medicine of the Federal University of
Pelotas. All cohort participants or their parents or guardians
(when they were <18 years at follow-up) signed an informed
consent agreeing to participate in the study.
Results
We evaluated 4,106 cohort members. Characteristics such as
sex, skin color, maternal schooling, and family income were
comparable among participants not included in this follow-up
and the original cohort members. Reasons for loss to follow-up
include mainly address not found, having moved away from
Pelotas, or death. The sample comprised almost the same pro-
portion of males (n ¼ 2,015) and females (n ¼ 2,091). More than
half (54.7%) had 9e11 years of schooling; 4.0% self-rated their
health as fair or poor; 7.5% presented low BMI; 27.7% were
overweight/obese; and 61.5% were physically active. The point
prevalence of medicine use in the 15 days preceding the inter-
view was 41.1% (95% CI 39.6e42.6), and of these, 65.6% used only
one drug, 23.4% two, and 10.9% three or more drugs. The pro-
portion of self-medication amongmedicine users was 65.1% (95%CI 62.8e67.4; n ¼ 1,687), and the point prevalence of self-
medicine was 26.7% (95% CI 25.4e28.1; n ¼ 4,106).
Table 1 lists the sample distribution, the point prevalence of
medicine use, and point prevalence of self-medication for any
drug reported and those of continuous use, stratiﬁed by gender
and according to socioeconomic position, level of education,
self-rated health, BMI, and level of physical activity. The point
prevalence of medicine use was 32.1% (95% CI 30.0e34.1) in
males and 49.8% (95% CI 47.6e51.9) in females (p < .001), while
the point prevalence of self-medication was 23.1% (95% CI
21.3e25.0) in males and 30.2% (95% CI 28.3e32.2) in females
(p < .001).
The overall point prevalence of continuous use of at least one
medicine was 12.3% (95% CI 11.2e13.3), with a difference by
gender (p < .001), 5.3% (95% CI 4.3e6.2) in males and 19.0% (95%
CI 17.3e20 7) in females. The overall point prevalence of
continuous medicine use for self-medication was 18.7% (95% CI
16.4e21.0), again with a difference (p < .001) by gender, 8.1%
(95% CI 5.7e10.6) among males and 26.4% (95% CI 23.0e30.0)
among females (Table 1). When contraceptives are excluded
from the analyses, females continue to signiﬁcantly use more
medicines than males.
Medicine use by quintiles of socioeconomic position showed
higher use among those in the upper quintiles. After stratifying
by gender, this association remained only among female ado-
lescents. This was found for both overall medicine use (female
adolescents in the upper quintile used 40% more medicines than
those in the lower one) and continuous medicine use (use 70%
Table 2
ATC classiﬁcation (levels 1 and 2) of 271 prescription drugs used for self-
medication
ATC classiﬁcation N %
MdMusculoskeletal system 70 25.8
M01dAnti-inﬂammatory and antirheumatic products 68
M02dTopical products for joint and muscular pain 1
M03dMuscle relaxants 1
GdGenitourinary system and sex hormones 68 25.1
G03dSex hormones and modulators of the
genital system
68
RdRespiratory system 37 13.7
R01dNasal preparations 15
R03dDrugs for obstructive airway diseases 10
R05dCough and cold medicines 1
R06dAntihistamines for systemic use 11
NdNervous system 33 12.2
N02dAnalgesics 11
N03dAntiepileptics 9
N05dPsycholeptics 5
N06dPsychoanaleptics 8
AdAlimentary tract and metabolism 26 9.6
A02dDrugs for acid-related disorders 8
A03dDrugs for functional gastrointestinal disorders 6
A04dAntiemetics and antinauseants 11
A08dAntiobesity preparations, excl. diet products 1
JdAnti-infectives for systemic use 25 9.2
J01dAntibacterials for systemic use 25
CdCardiovascular system 5 1.9
C03dDiuretics 2
C07dBeta-blocking agents 1
C09dAgents acting on the renineangiotensin system 2
HdSystemic hormonal preparations,
excl. sex hormones and insulins
4 1.5
H01dPituitary and hypothalamic hormones
and analogues
1
H02dCorticosteroids for systemic use 1
H03dThyroid therapy 2
BdBlood and blood forming organs 1 .4
B03dAntianemic preparations 1
DdDermatologicals 1 .4
D07dCorticosteroids, dermatological preparations 1
SdSensory organs 1 .4
S01dOphthalmologicals 1
Total 271 100%
ATC ¼ Anatomical Therapeutic Chemical.
Bold values are ATC classiﬁcation level 1. Other values are ATC level 2.
Table 3
Drugs often used for self-medication and OTC (nonprescription) or prescription
drug categorization
Drug N % OTCs Prescription
drugs
Paracetamol 443 34.7 x
Dipyrone 128 10.0 x
Dipyrone þ orphenadrine caffeine 88 6.9 x
ASA 69 5.4 x
Diclofenac 44 3.4 x
Ethinylestradiol þ levonorgestrel 34 2.7 x
Dipyrone þ caffeine þ isometheptene 32 2.5 x
Paracetamol þ phenylephrine
þ clorfeniram
32 2.5 x
Dipyrone þ caffeine þ chlorpheniramine 28 2.2 x
Papaverine þ ASA þ Atropa belladonna 24 1.9 x
Ibuprofen 21 1.7 x
ASA þ caffeine 20 1.6 x
Scopolamine 20 1.6 x
Amoxicillin 13 1.0 x
Other 280 21.9 d d
ASA¼ acetyl salicylic acid; OTC¼ over-the-counter; x¼ categorization in OTCs or
in prescription drugs.
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quintiles of socioeconomic position (Table 1).
We found greater medicine use among more educated ado-
lescents, both male (80% higher) and female (30% higher).
Continuous medicine use was higher (70%) among more
educated female adolescents. The point prevalence of self-
medication was 20% greater among those more educated but,
after stratifying by gender, this difference remained only for
overall medicine use among females (Table 1).
Medicine use increased as self-rated health decreased; we
observed 50% higher use among those who self-rated their
health as poor/very poor compared with those who self-rated it
as good/excellent. After stratifying by gender, we observed dif-
ferences only among male adolescents regarding overall medi-
cine use (70% higher among those who self-rated their health as
poor/very poor) and continuous medicine use (3.2 times greater
in those who self-rated it as poor/very poor). We also detected
differences in the point prevalence of self-medication among
those who self-rated their health as poor/very poor (50% higher
compared with those who self-rated it as good/excellent) in
both males (70% higher) and females (30% higher; Table 1).With respect to BMI, we found differences only regarding
overall medicine use in males; obese adolescents used 30% more
medicines than those with normal BMI. Physically active ado-
lescents used less medicine than those who were inactive.
However, the small difference found between them disappeared
after stratifying by gender. We saw no differences in self-
medication regarding BMI and level of physical activity.
We repeated the analyses on the association between self-
medication and socioeconomic position, education, self-rated
health, BMI, and physical activity after excluding contraceptives
from the analyses, and no changes were found (data not shown).
Of all medicines used (n ¼ 2,522), 58% were used by self-
medication. Of the medicines used, those for acute conditions
represented 75% of the sample, whereas those for continuous
use represented 25%. Continuous medicine use following cur-
rent medical prescriptionwas reported by 74.1%; 10.2% reported
noncurrent medical prescription, and 15.7% following
nonmedical advice. Among drugs continuously used (n ¼ 559),
sex hormones and modulators of the genital system and psy-
choanaleptics were the most frequently used accounting for
39% and 7.5% of continuous medicine use, respectively. Anal-
gesics and anti-inﬂammatory and antirheumatic products
accounted for 51.8% and 9.8% of all drugs used for acute con-
ditions (n ¼ 1,543), respectively.
Medicine use was also categorized as OTC or prescription
drugs. Although information was missing for 16.4% of the use
reported, 41.5% of all drugs used required medical advice. Yet,
31.0% were used for self-medication (n ¼ 271).
The anatomical groups (ATC1) and pharmacological/thera-
peutic subgroups (ATC2) of 271 prescription drugs used for self-
medication are listed in Table 2.
Table 3 lists the drugs most commonly used for self-
medication (around 80% of total drugs), as well as their distri-
bution between OTC and prescription drugs. The medicines
included in the “others” category (21.9% of all) represent over 150
products each with a proportion of use below 1%.
The main reasons reported for medicine use were headache
(30.9%), pain (17.1%), contraception (8.8%), infection (6.8%), cold/
ﬂu (6.3%), allergies (3.7%), abdominal pain (3.1%), gastric disor-
ders (2.6%), anxiety (2.2%), anemia (1.8%), asthma (1.7%),
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other reasons were reported in <1% of the medicines used.
Discussion
Our study used a population-based sample of all adolescents
aged 18 years born in the city of Pelotas, Brazil, in 1993. The age
of 18 years is particularly relevant for medicine use due to the
transition from adolescence to the legal deﬁnition of adulthood.
We highlighted the most frequently used medicines and the
reasons for use, as well as focused on self-medication, particu-
larly in the case of medicines requiring medical prescription.
Previous studies on self-medication in Brazil used different age
groups, nonrepresentative or small samples, or methodological
limitations that are not present in our survey [11,17,18].
Self-medication among adolescents aged 18 years presented a
high proportion (65.0%) among those using medicines. Previous
Brazilian studies found proportions of self-medication of 52.6%
[17] and 56.6% [18]. However, the sample of these studies differs
from ours, since they were conducted with children and ado-
lescents aged 14e18 and 0e18 years, respectively.
The overall point prevalence of self-medication (26.7%) found
in the sample studied is consistent with that reported in a
German population-based study (25.2%) that investigated 17,450
children and adolescents aged 0e17 years [14]. Contrasting to the
ﬁndings of Du and Knop, we did not observe a positive associa-
tion between self-medication and high-income (odds ratio 1.23).
We saw a higher point prevalence of medicine use for self-
medication among more educated adolescents, which corrobo-
rates results described by other authors [7,14,15].
Self-rated health is known to affect medicine use, both pre-
scription medication and self-medication. Thus, the point preva-
lence of medicine use was higher as expected among adolescents
who self-rated their health as poor/very poor. Investigators in
Germany also found higher prevalence of self-medication among
children and adolescents with poor health (odds ratio 1.29) [14].
Other Brazilian studies [5,15] also reported higher prevalence
of self-medication among females, which is partially not only due
to contraceptive use but also due to hormonal, care-seeking, and
cultural differences between men and women. Sex hormones
and modulators of the genital system are among the most
frequently used drugs through self-medication in our sample.
Medicine use in our sample ﬁtted into a pattern described in
the literature of a higher prevalence among females, more
educated individuals, those with poor/very poor self-rated
health, and those who are physically inactive. In addition, the
pharmacological groups of the most commonly used drugs
among adolescents are consistent with those described in the
literature [36,37].
A distinctive feature of our study is the categorization of OTC
and prescription drugs. It provided valuable input on the use of
drugs through self-medication that require medical advice and
monitoring (by skilled medical or dental provider). It should be
mentioned that in Brazilian pharmacies or drugstores, people
sometimes purchase medicines that require a medical pre-
scription without it, therefore not complying with the manda-
tory requirement of presenting and withholding a medical
prescription. Lack of control in the dispensing of prescription
medicines is a matter of concern for the regulatory agency from
the Brazilian Ministry of Health (ANVISA [Agência Nacional de
Vigilância Sanitária]). A task force was started in 2013 to tackle
this issue [38].Fortunately, most drugs the adolescents in our sample used
for self-medication were OTC drugs, which are safer. However, it
is concerning that one third of the drugs used for self-medication
(31.0%) were prescription drugs, suggesting that a large propor-
tion of the adolescents included in our study are not practicing
what is considered responsible self-medication according to the
WHO guidelines [1]. This ﬁnding conﬁrms a failure to comply
with current drug regulations, and that adolescents are at risk of
misusing prescription drugs. It calls for education interventions
to inform the public about the risks of self-medication with
prescription drugs, and most importantly, regulatory and
correction actions to ensure full compliance with mandatory
requirements.
An analysis of the drugs used showed that 58% were used for
self-medication, andmost of them (75%) were used to treat acute
conditions. The most often used medicines to treat acute con-
ditions were analgesics, which are OTC drugs that are quite safe
with rational use. People are supposed to engage in self-
medication for treating mild, self-limiting acute conditions.
The analysis of self-medicationwith continuous medicine use
revealed that adolescentsmostly used (74.3%) prescription drugs,
which may have damaging health effects. Misdiagnosis, delayed
medical care, bacterial resistance, hypersensitivity reactions, risk
of drug dependence or abuse, dangerous drug interactions,
serious adverse reactions, and hiding of symptoms that may be
part of a more serious disease are often adversely associatedwith
self-medication [4,5,7]. There is an increased risk when drugs
requiring monitoring are used for self-medication.
The adolescents in our sample most often reported the use of
self-medication for treating headaches and pain, which is
consistent with the most frequently used drugs reported, para-
cetamol and dipyrone. Our ﬁndings support those of other
research studies showing widespread use of analgesics for self-
medication [5,7,13,14,18]. The prevalence of pain among chil-
dren and adolescents has been identiﬁed as a major public health
problem; it is estimated that 15%e25% of all children and ado-
lescents suffer from chronic or recurrent pain conditions such as
headache and abdominal pain [21]. Although it was an expected
ﬁnding, the widespread use of this class of drugs evidences a
need to educate people on the risks of overuse of painkillers and
the importance of proper diagnosis and adequate treatment of
pain to prevent persistent or recurrent conditions.
Data collection took place between September 2011 (Spring)
and March 2012 (Summer). Therefore, it is expected that some
medicines that are used more frequently in the Winter were
underreported in our sample. The city of Pelotas is located in the
south of the country and presents well-deﬁned seasons.
A strength of our study is the use of a large birth cohort. In
addition, the study population was willing to participate and
voluntarily came to the clinic to attend the current visit as they
did in the past several times. Thus, we believe that we were able
to collect good quality data that may be representative of the
reality of young people living in other areas/regions with similar
characteristics.
However, the study ﬁndings are limited by the use of self-
report. Self-report may be affected by forgetfulness and recall
errors, misclassiﬁcation of medicines, ignorance of the actual
reasons for drug use, and underreporting of drug use when
adolescents intentionally omit the use of certain drugs such as
steroids, contraceptives, or abortifacients or do not knowwhich
medicines they used as their drug use is controlled by their
parents or caregivers. Some of the medicines classiﬁed under
A.D. Bertoldi et al. / Journal of Adolescent Health 55 (2014) 175e181180“noncurrent medical prescription,” treated here as self-
medication, might be cases of reﬁlling. The method used for
data collection does not allow us to detect such cases, but
because only 5% of the medicines were classiﬁed into this group,
the likely impact on the study ﬁndings is minimal.
It should be mentioned, however, that appropriate self-
medication, whereby individuals treat their ailments with OTC
medicines following a health provider’s advice, is a valuable
practice to health systems as people are responsible for their own
self-care and can promptly manage mild, self-limiting condi-
tions, reducing the demand for care services.
Unfortunately, due to the fact that this studywas not designed
to identify adverse effects of self-medication, it is not possible to
present data about unfavorable outcomes related to medicines
used in this population.
Self-medication is a concerning issue in Brazil because most
people do not seek advice from a skilled health-related provider
such as a pharmacist. Most people have easy access to pharma-
cists, and they play a strategic role offering relevant information
advice on drug use, especially OTC drugs, and promoting rational
drug use [39]. Our ﬁndings suggest that Brazilian pharmacists
have been neglecting their crucial role in promoting rational
drug use, a strategy identiﬁed as important for decades by the
WHO [1].
Another study using this same birth cohort assessed conti-
nuity of patterns of drug use and self-medication from childhood
to adolescence. They found that 28% of adolescents who engaged
in self-medication at age 11would also engage in self-medication
at age 15, while only 19% of those who did not engage in self-
medication at age 11 would engage in self-medication at age 15
[11]. Self-medication among young people on the path to
adulthood may follow a pattern of drug use that may perpetuate
into adulthood. Family members, especially the mother [18], has
been described as promoters of self-medication [13,18], sug-
gesting this behavior may be acquired and encouraged at home.
Strategies to promote rational drug use in this population are
needed, and it is crucial to develop education programs aligned
with their needs. Substantial advances can be made with the
use of tools that are part of their everyday life such as social
media, virtual games, blogs, and microblogs. Also, formally
addressing issues related to drug use, from elementary and high
school, is necessary as it can potentially lead to behavior
changes toward the rational use of medicines. Because analge-
sics were the most frequently used medicines in this popula-
tion, we suggest future studies should collect more detailed
data about their use, including a clear differentiation between
acute and chronic pain.
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